As of 2025-06-30, the Relative Valuation of Theravance Biopharma Inc (TBPH) is (13.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.22 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is -224.5%.
The range of the Relative Valuation is (13.77) - (14.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 12.0x | 10.8x |
| Forward P/E multiples | 11.8x - 14.6x | 13.2x |
| Fair Price | (13.77) - (14.00) | (13.97) |
| Upside | -222.7% - -224.8% | -224.5% |
| Date | P/E |
| 2025-06-27 | -9.62 |
| 2025-06-26 | -9.20 |
| 2025-06-25 | -9.07 |
| 2025-06-24 | -9.15 |
| 2025-06-23 | -9.06 |
| 2025-06-20 | -9.11 |
| 2025-06-18 | -9.10 |
| 2025-06-17 | -9.09 |
| 2025-06-16 | -9.21 |
| 2025-06-13 | -9.16 |
| 2025-06-12 | -9.09 |
| 2025-06-11 | -9.09 |
| 2025-06-10 | -9.20 |
| 2025-06-09 | -9.39 |
| 2025-06-06 | -9.64 |
| 2025-06-05 | -9.23 |
| 2025-06-04 | -9.44 |
| 2025-06-03 | -9.53 |
| 2025-06-02 | -9.56 |
| 2025-05-30 | -7.85 |
| 2025-05-29 | -7.97 |
| 2025-05-28 | -7.84 |
| 2025-05-27 | -7.95 |
| 2025-05-23 | -7.97 |
| 2025-05-22 | -8.13 |
| 2025-05-21 | -8.07 |
| 2025-05-20 | -8.10 |
| 2025-05-19 | -8.05 |
| 2025-05-16 | -7.89 |
| 2025-05-15 | -7.83 |
| 2025-05-14 | -7.21 |
| 2025-05-13 | -7.64 |
| 2025-05-12 | -7.54 |
| 2025-05-09 | -7.70 |
| 2025-05-08 | -8.49 |
| 2025-05-07 | -8.56 |
| 2025-05-06 | -8.65 |
| 2025-05-05 | -8.82 |
| 2025-05-02 | -8.89 |
| 2025-05-01 | -8.91 |
| 2025-04-30 | -8.37 |
| 2025-04-29 | -8.14 |
| 2025-04-28 | -8.36 |
| 2025-04-25 | -8.36 |
| 2025-04-24 | -8.18 |
| 2025-04-23 | -8.10 |
| 2025-04-22 | -7.98 |
| 2025-04-21 | -7.83 |
| 2025-04-17 | -7.39 |
| 2025-04-16 | -7.37 |